Accounts Payable and Accrued Expenses and Other Current Liabilities

9 Months Ended

Sep. 30, 2026

8. Accounts Payable and Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):


	September 30, 2026		December 31, 2025
Accrued compensation and ESPP contributions	$	2,667	$	2,693
Accrued outsourced non-clinical studies		1,360		651
Accrued contract manufacturing costs		1,535		223
Accrued clinical trial costs		50		49
Accrued other		617		323
Total accrued expenses and other current liabilities	$	6,229	$	3,939